Cargando…

Functional status analysis of RNH1 in bladder cancer for predicting immunotherapy response

Bladder cancer (BLCA) typically has a poor prognosis due to high rates of relapse and metastasis. Although the emergence of immunotherapy brings hope for patients with BLCA, not all patients will benefit from it. Identifying some markers to predict treatment response is particularly important. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Sen, Ran, Jun, Fan, Zhouqian, Liu, Mingyou, Wu, Liang, Li, Qiude, Peng, Jian, Hu, Zuquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400633/ https://www.ncbi.nlm.nih.gov/pubmed/37537337 http://dx.doi.org/10.1038/s41598-023-39827-7

Ejemplares similares

Division of labor among Mycobacterium smegmatis RNase H enzymes: RNase H1 activity of RnhA or RnhC is essential for growth whereas RnhB and RnhA guard against killing by hydrogen peroxide in stationary phase
por: Gupta, Richa, et al.
Publicado: (2017)

Role of RNH1 in the regulation of RNase H2 function
por: Kind, B, et al.
Publicado: (2015)

Angiogenin (ANG)—Ribonuclease Inhibitor (RNH1) System in Protein Synthesis and Disease
por: Sarangdhar, Mayuresh Anant, et al.
Publicado: (2021)

LRR-protein RNH1 dampens the inflammasome activation and is associated with COVID-19 severity
por: Bombaci, Giuseppe, et al.
Publicado: (2022)

Human molecular genetics sheds light on the physiological significance of ribonuclease inhibitor (RNH1)
por: Sarangdhar, Mayuresh Anant, et al.
Publicado: (2023)

PTEN Modulates miR-21 Processing via RNA-Regulatory Protein RNH1
por: Kim, Youn-Jae, et al.
Publicado: (2011)

IRF7 and RNH1 are modifying factors of HIV-1 reservoirs: a genome-wide association analysis
por: Zhang, Zhenhua, et al.
Publicado: (2021)

The Deletion of rnhB in Mycobacterium smegmatis Does Not Affect the Level of RNase HII Substrates or Influence Genome Stability
por: Minias, Alina E., et al.
Publicado: (2015)

Ribonuclease inhibitor 1 (RNH1) deficiency cause congenital cataracts and global developmental delay with infection-induced psychomotor regression and anemia
por: Hedberg-Oldfors, Carola, et al.
Publicado: (2023)

Robust Prediction of Prognosis and Immunotherapy Response for Bladder Cancer through Machine Learning Algorithm
por: Hu, Shanshan, et al.
Publicado: (2022)

Identification of immunotherapy-related lncRNA signature for predicting prognosis, immunotherapy responses and drug candidates in bladder cancer
por: Hui, Pengyu, et al.
Publicado: (2023)

The mutation T477A in HIV-1 reverse transcriptase (RT) restores normal proteolytic processing of RT in virus with Gag-Pol mutated in the p51-RNH cleavage site
por: Abram, Michael E, et al.
Publicado: (2010)

Iron Control in Liquid Effluents: Pseudo-Emulsion Based Hollow Fiber Membrane with Strip Dispersion Technology with Pseudo-Protic Ionic Liquid (RNH(3)(+)HSO(4)(−)) as Mobile Carrier
por: Alguacil, Francisco Jose, et al.
Publicado: (2023)

Pyroptosis-Related Patterns Predict Tumor Immune Landscape and Immunotherapy Response in Bladder Cancer
por: Yan, Yilin, et al.
Publicado: (2022)

DNA Methylation Modification Map to Predict Tumor Molecular Subtypes and Efficacy of Immunotherapy in Bladder Cancer
por: Ye, Fangdie, et al.
Publicado: (2021)

Immune‐related signature predicts the prognosis and immunotherapy benefit in bladder cancer
por: Wang, Yejinpeng, et al.
Publicado: (2020)

A single-sample mRNA molecular classification of bladder cancer predicting prognosis and response to immunotherapy
por: Jin, Kun, et al.
Publicado: (2022)

Current Status in Rechallenge of Immunotherapy
por: Hu, Han, et al.
Publicado: (2023)

Identification of an immunotherapy-responsive molecular subtype of bladder cancer
por: Song, Bic-Na, et al.
Publicado: (2019)

Immunotherapy for bladder cancer
por: Fuge, Oliver, et al.
Publicado: (2015)

Serum CCL27 predicts the response to Bacillus Calmette-Guerin immunotherapy in non-muscle-invasive bladder cancer
por: Zhong, Wenlong, et al.
Publicado: (2020)

Tumor immune microenvironment-based classifications of bladder cancer for enhancing the response rate of immunotherapy
por: Meng, Jialin, et al.
Publicado: (2021)

Immune Microenvironment Terms Signature Robustly Predicts the Prognosis and Immunotherapy Response in Bladder Cancer Based on Large Population Cohorts
por: Liang, Shengjie, et al.
Publicado: (2022)

Predictive Biomarkers of Bacillus Calmette-Guérin Immunotherapy Response in Bladder Cancer: Where Are We Now?
por: Lima, Luís, et al.
Publicado: (2012)

Do we have biomarkers to predict response to neoadjuvant and adjuvant chemotherapy and immunotherapy in bladder cancer?
por: Wezel, Felix, et al.
Publicado: (2017)

N6-Methylandenosine-Related lncRNAs Predict Prognosis and Immunotherapy Response in Bladder Cancer
por: Zhang, Yuying, et al.
Publicado: (2021)

Identification of tumor microenvironment-related signature for predicting prognosis and immunotherapy response in patients with bladder cancer
por: Yao, Zhihao, et al.
Publicado: (2022)

Cytoskeleton regulator RNA expression on cancer-associated fibroblasts is associated with prognosis and immunotherapy response in bladder cancer
por: Wu, Yucai, et al.
Publicado: (2023)

Complete Response With Immunotherapy: A Case of Metastatic Bladder Cancer
por: Singh, Balraj, et al.
Publicado: (2021)

Immune Signature-Based Risk Stratification and Prediction of Immunotherapy Efficacy for Bladder Urothelial Carcinoma
por: Liang, Fangfang, et al.
Publicado: (2021)

An Unfolded Protein Response Related Signature Could Robustly Predict Survival Outcomes and Closely Correlate With Response to Immunotherapy and Chemotherapy in Bladder Cancer
por: Zhang, Facai, et al.
Publicado: (2021)

Cuproptosis depicts tumor microenvironment phenotypes and predicts precision immunotherapy and prognosis in bladder carcinoma
por: Li, Huihuang, et al.
Publicado: (2022)

BCG in Bladder Cancer Immunotherapy
por: Jiang, Song, et al.
Publicado: (2022)

APOBEC3B and CD274 as Combined Biomarkers for Predicting Response to Immunotherapy in Urothelial Carcinoma of the Bladder
por: Zhang, Chuanhao, et al.
Publicado: (2022)

High expression of COL6A1 predicts poor prognosis and response to immunotherapy in bladder cancer
por: Zhang, Xuezhou, et al.
Publicado: (2022)

Identification of cuproptosis-related long noncoding RNA signature for predicting prognosis and immunotherapy response in bladder cancer
por: Huang, Gaomin, et al.
Publicado: (2022)

Characterization of hypoxia response patterns identified prognosis and immunotherapy response in bladder cancer
por: Cao, Rui, et al.
Publicado: (2021)

Hypoxic Characteristic Genes Predict Response to Immunotherapy for Urothelial Carcinoma
por: Hong, Shuo, et al.
Publicado: (2021)

An innovative risk index based on neutrophils and macrophages can effectively predict prognosis and immunotherapy response in patients with muscle-invasive bladder cancer
por: Zhang, Xingxing, et al.
Publicado: (2023)

An N-Cadherin 2 expressing epithelial cell subpopulation predicts response to surgery, chemotherapy and immunotherapy in bladder cancer
por: Gouin, Kenneth H., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j6bgbvslk4av0p5kah91avn0c1